Drug Database
DO

donepezil (IPI301 / donepezil, iCure / Donerion)

✓ Approved

Icure Pharmaceutical Incorporation · ACHE · 小分子

什么是 donepezil?

donepezil 是一种小分子,由Icure Pharmaceutical Incorporation研发。该药已获批,用于治疗相关适应症,给药途径:Transdermal。

药物档案

商品名IPI301, donepezil, iCure, Donerion
公司Icure Pharmaceutical Incorporation
药物类别小分子
分子靶点ACHE
给药途径Transdermal
状态Approved

作用机制

分子靶点

donepezil 作用于 1 个分子靶点:

ACHEacetylcholinesterase (Cartwright blood group) (N-ACHE, ACEE)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

donepezil 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersDementia Alzheimer's type✓ Approved

相关研究文献

PubMedBMC neurology2026-11-19

Therapeutic regimen for AD-derived MCI: the effect of sodium oligomannate (GV-971) combined with donepezil on patients' cognitive function and hippocampal atrophy rate.

Jiao Fucheng F, Li Yuhua Y, Zhang Lina L, Fang Caixia C et al.

To investigate the clinical efficacy of sodium oligomannate (GV-971) combined with donepezil in the treatment of patients with mild cognitive impairment (MCI) in Alzheimer's disease (AD). This non-randomized, open-label, retrospective analytic study included 100 patients with AD-derived MCI who were treated in our hospital between May 2023 and May 2024, and were divided into two groups according to the different treatment modalities recorded in the electronic medical record system: 44 cases in the control group (donepezil), and 56 cases in the observation group (sodium oligomannate (GV-971) combined with donepezil). Cognitive function, biochemical markers (homocysteine (Hcy), S100 calcium binding protein B (S100β), neuron-specific enolase (NSE)), serum intestinal flora metabolic markers (phenylalanine (Phe), short-chain fatty acids (SCFA), γ-aminobutyric acid (GABA), acetylcholine (Ach)), hippocampal volume, and adverse effects were collected and compared between the two groups, and adverse reactions were recorded. After treatment, the comparison of various scores of cognitive function, Hcy, S100β, NSE, Phe, SCFA, GABA, and Ach between the patients in the observation group and the control group showed statistically significant differences (P<0.05); after treatment, the comparison of left hippocampal volume, right hippocampal volume, and total volume between the observation group and the control group did not show any statistically significant difference (P>0.05). In contrast, the calculated hippocampal atrophy rate-derived from the percentage change relative to baseline volume-was significantly lower in the observation group than in the control group (P < 0.05). Regarding safety, the total incidence of adverse reactions was 10.71% (6/56) in the observation group versus 9.09% (4/44) in the control group, with no statistically significant difference between the two groups (P > 0.05). The combination of sodium oligomannate (GV-971) and donepezil was associated with more favorable changes in cognitive function, neuronal injury biomarkers, serum markers of gut microbiota metabolism, and a slower observed rate of hippocampal atrophy in patients with AD-derived MCI. These associations do not imply causation, and the combination regimen did not significantly increase adverse reactions in this cohort.

PMID 43052811
阅读全文 →
PubMedFrontiers in neurology2026-11-17

Integrative approaches to acupuncture therapies for post-stroke mild cognitive impairment: a systematic review and network meta-analysis.

Huang Shi-Le SL, Hui You-Yi YY, Zhang Wei W, Tang Xing X et al.

Post-stroke mild cognitive impairment (PSMCI) frequently occurs after stroke and substantially restricts patients' functional restoration and overall quality of life. Acupuncture has been widely adopted as an adjunctive intervention; however, the relative efficacy and safety profiles among different acupuncture modalities for PSMCI have not been clearly established. To assess the comparative effectiveness and safety of multiple acupuncture therapies for treating PSMCI via network meta-analysis. RCTs on acupuncture for PSMCI published from their inception to October 2025 were retrieved from nine databases and four clinical trial registries. Study quality was assessed via the Cochrane risk of bias tool. Meta-analysis was performed with ReviewManager and Stata software. In total, 47 RCTs featuring 3,680 participants and 15 types of acupuncture-related interventions were included. Electroacupuncture combined with Moxibustion showed the highest efficacy in improving both MoCA score [MD = 5.42, 95%CI (2.10, 8.74)] and total effective rate. Electroacupuncture plus HBOT [MD = 8.00, 95%CI (5.19, 10.82)] and manual acupuncture plus rTMS [MD = 3.42, 95%CI (0.87, 5.97)] were most effective in improving MMSE. Manual acupuncture plus donepezil [MD = 8.67, 95%CI (5.47, 11.88)] and Electroacupuncture plus cognitive training [MD = -8.09, 95%CI (-10.56, -5.62)] achieved the greatest improvement in Barthel index. Moreover, the adverse events of these interventions were acceptable. This study suggested that acupuncture was effective and safe for PSMCI treatment. However, the poor methodological quality and uneven evidence quality of existing studies warrant further rigorously designed trials to confirm our findings. https://www.crd.york.ac.uk/prospero/, identifier CRD420251165945.

PMID 43041399
阅读全文 →
PubMedIn silico pharmacology2026-11-15

Substituent effects on electronic properties and predicted acetylcholinesterase binding potential of donepezil analogues: a DFT, molecular docking, and ADMET study with dynamics assessment of the lead candidate.

Ejaz Muhammad Mohsin MM, Iftikhar Hamza H, Al-Namshah K S KS, Khan Saira S et al.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the most common cause of dementia in older people. Donepezil is an acetylcholinesterase inhibitor used for symptomatic management of AD. Due to its clinically established AChE inhibition; it was used as a reference. In this study, a series of donepezil derivatives (MH-1 to MH-5) were designed by introducing a para substituent (NH2, NO2, Cl, OH or OCH3) on the benzyl moiety and systematically investigated along with the R using density functional theory, time-dependent DFT, molecular docking, and in silico pharmacokinetics analysis. The geometry optimization and electronic structure calculations were performed using the B3LYP/6-311G (d, p) level. Frontier molecular orbital analysis indicated reduced energy gaps in MH-1 and MH-2. The in silico molecular docking analysis of all derivatives and the R was performed against the acetylcholinesterase receptor (PDB ID 4EY7), where MH-1, MH-2, and MH-4 showed Vina scores equal to the R (- 12.2 kcal/mol). MH-4 was selected for a single 300 ns molecular dynamics simulation (unlike MH-1 and MH-2, it had no predicted mutagenicity alert). The protein backbone RMSD stayed mostly between 0.15 and 0.22 nm, and the ligand stayed in contact with the protein while changing its conformation and orientation. MM-GBSA enthalpy was stable across sampling densities (ΔH ≈ -24.6 kcal/mol), whereas the Interaction Entropy-corrected binding free energy varied with the number of frames analysed (ΔG = - 9.76 to - 15.71 kcal/mol, standard error ≈ 3.7-4.0 kcal/mol). Moreover, ADMETlab 3.0 predicted high intestinal absorption. ProTox 3.0 predicted several toxicity alerts for all compounds, including immunotoxicity and respiratory toxicity; MH-1 and MH-2 were also flagged for mutagenicity. In summary, MH-4 is proposed as a candidate for experimental evaluation. All results are computational predictions and require experimental validation. The online version contains supplementary material available at https://doi.org/10.1007/s40203-026-00786-2.

PMID 43034395
阅读全文 →
PubMedNpj viruses2026-11-12

Genome-wide screening identifies unique host-directed drugs and pro-viral signalling pathways for SARS-CoV-2.

Khan Juveriya Qamar JQ, Rajamanickam Karthic K, Vizeacoumar Frederick S FS, Balouchi Mahrokh M et al.

SARS-CoV-2 is a positive-sense RNA virus that was responsible for the devastating COVID-19 pandemic. Although the current disease burden is less severe, there are limited treatment options, and a looming threat of the emergence of variants and future pandemics. To address these challenges, we performed genome-wide CRISPR knockout screens in a novel human lung cell line NCI-H23ACE2, as well as in HEK293TACE2 cells, with SARS-CoV-2 Wuhan strain, and identified several host-dependency factors including NRAS, KAT5, HTR3E and GNL3L. Drugs targeting some of these dependency factors, donepezil, dH-ergocristine, trametinib and sorafenib, showed effective pan-coronaviral inhibition in cell lines. Trametinib also showed inhibition of SARS-CoV-2 Delta variant in primary human airway tissue model (ALI). We also demonstrate that SARS-CoV-2 inhibits IFN-β induction through an NRAS/Raf/MEK/ERK signaling pathway dependent mechanism. Our study highlights the efficiency of a bilateral approach of gene silencing and antiviral screening to identify host-dependency factors and effective antivirals.

PMID 43015343
阅读全文 →
PubMedBiochemical pharmacology2026-11-12

Irosustat and STX140 improve cognitive function and modulate amyloid, oxidative stress, and inflammatory pathways in experimental Alzheimer's disease.

Anbar Hanan S HS, Lozon Yosra Y, Khodr Valia V, Jabr Rim R et al.

Alzheimer's disease (AD) is currently the most prevalent neurodegenerative disorder affecting the geriatric population. The pathology of AD has been described as neuronal loss caused by the accumulation of beta-amyloid plaques and the formation of neurofibrillary tangles resulting from tau protein phosphorylation. This study aimed to investigate the therapeutic potential of steroid sulfatase inhibition using two drugs, the clinical steroid sulfatase inhibitor Irosustat and the multi-targeting preclinical candidate STX140, in scopolamine-induced AD in male Wistar rats compared to Donepezil as a standard drug. Behavioral tests such as the Open Field Test, Elevated Plus Maze Test, and Morris Water Maze Test were conducted to confirm the disease state and assess any improvement. At the end of the study, the animals were dissected to collect blood and brain samples for morphological, histological, immunohistochemical, biochemical, quantitative polymerase chain reaction and western blotting analyses. Treatment with Irosustat or STX140 improved learning, memory, and cognitive function compared with the disease group. The treated groups showed lowered brain tissue Aβ-40 & 42 levels, acetylcholinesterase activity, oxidative stress, and inflammatory markers. Morphological assessments showed that the drugs protected against brain atrophy and neuronal loss. Irosustat and STX140 are therefore promising therapeutic candidates for the management of Alzheimer's Disease.

PMID 43020291
阅读全文 →
PubMedBMC cardiovascular disorders2026-11-11

Amantadine, donepezil and memantine associated arrhythmia in an elderly patient.

Atmaca Hasan H, Gürbüz Doğaç Çağlar DÇ, Erol Mustafa Kemal MK, Yetkin Ertan E

CASE İNFORMATION: A 78-year-old male patient was referred to the cardiology clinic for mild dyspnea. Initial electrocardiography (ECG) showed sinus bradycardia at a rate of 59 beats/min, a right bundle branch block (RBBB), a first-degree atrioventricular (AV) block, and a normal QTc duration. One month later, the patient was readmitted because of worsening dyspnea and an arrhythmia detected by a neurologist. The patient stated that the neurologist had prescribed donepezil (5 mg) and memantine (10 mg) combined, along with amantadine (100 mg) for dementia. His control ECG revealed interpolated ventricular premature contractions (VPCs) in a trigeminy pattern, in addition to the first-degree AV block and RBBB. After consultation with the neurologist, the anti-dementia medications were discontinued. We believe the combination of amantadine, donepezil, and memantine caused the interpolated VPCs, as the arrhythmia disappeared after drug cessation.

PMID 43009756
阅读全文 →

注册免费账户还可查看另外 5584 篇文献

免费注册查看全部文献 →

了解更多donepezil